Bone Tumor Ablation

ABSTRACT OF THE YEAR: Medtronic’s OPuS One study of the OsteoCool™ RF Ablation platform.
Join the presentations Wednesday 11:00 a.m. ET and Friday 10:00 a.m. ET
ABSTRACT OF THE YEAR: Medtronic’s OPuS One study of the OsteoCool™ RF Ablation platform.
Join the presentations Wednesday, 11:00 ET and Friday, 10:00 ET

Featured Events

Abstracts

Radiofrequency Ablation for the Palliative Treatment of Osseous Metastases: 
Final Results from a Multicenter Study (OPuS One)

Plenary Session - Abstract Of The Year

Wednesday, March 24
11:00 a.m.-12:00 p.m ET
WATCH PRESENTATION

Improvement in Quality of Life in Patients Treated for Painful Osseous Metastases with Radiofrequency Ablation: 
The OPuS One Study

Concurrent Sessions:  MSK Interventions/Pediatric IR

Friday, March 26
10:00-11:00 a.m. ET
WATCH PRESENTATION

 

 

symposium

OsteoCool™ RF Ablation System for Bone Metastases:
Clinically Significant Pain Relief and Improved Quality of Life
Friday, March 26
4:10-4:50 p.m. ET
WATCH SYMPOSIUM

VIDEOS

Osteocool™ radiofrequency ablation

OPuS One - The largest prospective study on the performance and safety of RFA for the treatment of palliative bone metastases to date.

Attend our abstracts and symposium for more information.

SUPPORT DOCUMENTATION

pdf OPuS One Study Summary (.pdf)

Learn more about the OPuS One study.

276KB

pdf OsteoCool™ RF Ablation Brochure (.pdf)

Learn more about OsteoCool™RF Ablation.

3.2MB

talk to a rep

Talk to a Medtronic representative at SIR and attend our abstract presentations to learn more about the clinical evidence supporting OsteoCool™ RF ablation.
 
CONTACT

Would you like to learn more about Medtronic products?

Contact us

NEW 12-MONTH OPUS ONE CLINICAL STUDY RESULTS

Access the Data

DON'T MISS A MOMENT

Explore our SIR 2021 events schedule.

SEE EVENT LINEUP